Use of hyaluronic acid preparations for treatment of osteoarthritis of major ligaments

Oleksiy  Kalashnikov; Oleksiy Sulyma; Taras  Osadchuk; Volodymyr  Zayets; Taras  Nizalov; Roman  Kozak; Pavlo  Chernyak

doi:10.31636/pmjua.v6i2.4

Автор(и)

Oleksiy Kalashnikov State Institution “Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine”, Kyiv
Oleksiy Sulyma State Institution “Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine”, Kyiv
Taras Osadchuk State Institution “Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine”, Kyiv
Volodymyr Zayets State Institution “Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine”, Kyiv
Taras Nizalov State Institution “Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine”, Kyiv
Roman Kozak State Institution “Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine”, Kyiv
Pavlo Chernyak State Institution “Institute of Traumatology and Orthopedics of the National Academy of Medical Sciences of Ukraine”, Kyiv

DOI:

https://doi.org/10.31636/pmjua.v6i2.4

Ключові слова:

остеоартроз великих суглобів, лікування, препарати гіалуронової кислоти, ефективність

Анотація

Авторами статті проаналізовано досвід вітчизняних та зарубіжних спеціалістів з ефективності використання препаратів ГК в лікуванні остеоартрозу великих суглобів.

Мета дослідження. Провести аналіз джерел літератури з метою визначення ефективності використання препаратів ГК в лікуванні остеоартрозу великих суглобів.

Матеріали і методи. Статті в профільних наукових журналах та збірках, інтернет-ресурс.

Результати. Проведений аналіз літературних джерел визначив важливу роль ГК у живленні та функціонуванні суглобового хряща. Дослідники схиляються до думки, що ідеальний препарат ГК повинен бути максимально наближеним до фізіологічної ГК синовіальної рідини суглоба. Цим параметрам повністю відповідає розроблений препарат Артро-Патч.

Висновки. Застосування сучасних ін`єкційних препаратів ГК доцільно використовувати при 1–3 стадії ОА. Протизапальний ефект препаратів ГК обумовлює можливість зменшення дози і часу прийому нестероїдних протизапальних засобів і як наслідок – зниження ризику розвитку багатьох несприятливих побічних ефектів НПЗЗ. Високий рівень безпеки препаратів ГК, відсутність серйозних побічних ефектів при їх тривалому застосуванні зумовлюють їх широке використання в клінічній практиці сучасних ортопедів

Завантаження

Дані завантаження ще не доступні.

Посилання

Comfort T, Baste V, Froufe MA, Namba R, Bordini B, Robertsson O, et al. International Comparative Evaluation of Fixed-Bearing Non-Posterior-Stabilized and Posterior-Stabilized Total Knee Replacements. Journal of Bone and Joint Surgery [Internet]. Ovid Technologies (Wolters Kluwer Health); 2014 Dec 17;96(Supplement_1):65–72. Available from: https://doi.org/10.2106/jbjs.n.00462

Riddle DL, Perera RA, Stratford PW, Jiranek WA, Dumenci L. Progressing Toward, and Recovering From, Knee Replacement Surgery: A Five-Year Cohort Study. Arthritis & Rheumatism [Internet]. Wiley; 2013 Nov 27;65(12):3304–13. Available from: https://doi.org/10.1002/art.38139

Skyttä ET, Haapamäki V, Koivikko M, Huhtala H, Remes V. Reliability of the hip-to-ankle radiograph in determining the knee and implant alignment after total knee arthroplasty. Acta Orthop Belg. 2011 Jun 1;77(3):329-35.

Nasonova VA. Rheumatic diseases in Russia at the beginning of the XXI century. Scientific and practical. rheumatol. 2003; 6-10.

Gaiko GV. Modern approaches to the prevention and treatment of osteoarthritis. Chronicle of Traumatology and Orthopedics. 2008; 1(2):157-160.

Vaidya C, Alvarez E, Vinciguerra J, Bruce DA, DesJardins JD. Reduction of Total Knee Replacement Wear with Vitamin E Blended Highly Cross-Linked Ultra-High Molecular Weight Polyethylene. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine [Internet]. SAGE Publications; 2010 Jul 29;225(1):1–7. Available from: https://doi.org/10.1243/09544119jeim774

Whiteside LA. Assess and Release the Tight Ligament. Total Knee Arthroplasty [Internet]. Springer-Verlag; 170–6. Available from: https://doi.org/10.1007/3-540-27658-0_26

Zorya VI. Deforming arthrosis of the knee joint: A guide for doctors. Moscow. Litterra; 2010. 320.

Kalashnikov AV, Osadchuk TI, Lazarev IA, Kalashnikov OV. Results of mathematical modeling of the stress-strain state of endoprosthesis components when performing total knee arthroplasty. Problems of traumatology and osteosynthesis; 2019; 4:4-23.

Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: A disease of the joint as an organ. Arthritis & Rheumatism [Internet]. Wiley; 2012 May 25;64(6):1697–707. Available from: https://doi.org/10.1002/art.34453

Hayko HV, Kalashnikov OV. Osteoarthritis of the hip joint: factors of origin and progression, treatment and prevention. Scientific Journal of the Ministry of Health of Ukraine; 2014; 5(1):70−77.

Kalashnikov OV. Peculiarities of development and course of osteoarthritis of the hip joint of dysplastic origin. Ukrainian Journal of Extreme Medicine; 2013; 14(1):34−37.

Hayko HV, Kalashnikov OV, Brusko AT. Post-traumatic coxarthrosis and features of its course. Sports Medicine; 2013; 1:47−50.

Baranovskiy DS, Demchenko AG, Oganesyan RV, Lebedev GV, Berseneva DA. Obtaining acellular matrix of tracheal cartilage for tissue engineering structures. Annals of the Russian academy of medical sciences [Internet]. Paediatrician Publishers LLC; 2017 Jul 15;72(3). Available from: https://doi.org/10.15690/vramn723

Bykov VL. Histology, cytology, and embryology: atlas: textbook. Moscow. GEOTAR-Media; 2013.

Nozdrin VI. Histology in a summary: text and atlas. Moscow. Retinoids; 2019.

Olyunin YA. Use of hyaluronic acid preparations in the combination therapy of osteoarthritis. Modern Rheumatology Journal [Internet]. IMA Press, LLC; 2016 Jan 1;10(2):64–9. Available from: https://doi.org/10.14412/1996-7012-2016-2-64-69

Peyron JG, JG P, EA B. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints.

Belenky AG. Hyaluronic acid preparations in the treatment of osteoarthritis. Textbook. Moscow. 2005.

Zhu J, Lei P, Hu Y. Intraarticular hyaluronate injection for knee osteoarthritis—reconsider the rationale. Annals of translational medicine. 2015 Sep;3(15).

Altman RD, Schemitsch E, Bedi A. Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid. Seminars in Arthritis and Rheumatism [Internet]. Elsevier BV; 2015 Oct;45(2):132–9. Available from: https://doi.org/10.1016/j.semarthrit.2015.04.013

Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis – meta-analysis. Osteoarthritis and Cartilage [Internet]. Elsevier BV; 2011 Jun;19(6):611–9. Available from: https://doi.org/10.1016/j.joca.2010.09.014

McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage [Internet]. Elsevier BV; 2014 Mar;22(3):363–88. Available from: https://doi.org/10.1016/j.joca.2014.01.003

Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, Fischer MA, et al. Effects of Noncardiovascular Comorbidities on Antihypertensive Use in Elderly Hypertensives. Hypertension [Internet]. Ovid Technologies (Wolters Kluwer Health); 2005 Aug;46(2):273–9. Available from: https://doi.org/10.1161/01.hyp.0000172753.96583.e1

Caporali R, Cimmino MA, Sarzi-Puttini P, Scarpa R, Parazzini F, Zaninelli A, et al. Comorbid Conditions in the AMICA Study Patients: Effects on the Quality of Life and Drug Prescriptions by General Practitioners and Specialists. Seminars in Arthritis and Rheumatism [Internet]. Elsevier BV; 2005 Aug;35(1):31–7. Available from: https://doi.org/10.1016/j.semarthrit.2005.02.004

Conaghan PG. Parallel evolution of OA phenotypes and therapies. Nature Reviews Rheumatology [Internet]. Springer Science and Business Media LLC; 2013 Jan 8;9(2):68–70. Available from: https://doi.org/10.1038/nrrheum.2012.225

Chichasova NV, Imametdinova GR. The 2014 guidelines for the management of osteoarthritis: Place of hyaluronic acid preparations. Modern Rheumatology Journal [Internet]. IMA Press, LLC; 2015 Jan 1;9(4):37–43. Available from: https://doi.org/10.14412/1996-7012-2015-4-37-43

Protsenko HO, Ivanova KA. An alternative approach to the treatment of osteoarthritis with comorbid conditions. Medicines of Ukraine; 2013; 1:84–88.

Alekseeva LI. New approaches to the management of patients with osteoarthritis in real clinical practice. Practical Medicine; 2015; 2(3):77-83.

Balabanova RM. Place of hyaluronic acid preparations in therapy for osteoarthrosis. Modern Rheumatology Journal [Internet]. IMA Press, LLC; 2014 Sep 22;(3):73. Available from: https://doi.org/10.14412/1996-7012-2014-3-73-76

Bannuru RR, Vaysbrot EE, Sullivan MC, McAlindon TE. Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism [Internet]. Elsevier BV; 2014 Apr;43(5):593–9. Available from: https://doi.org/10.1016/j.semarthrit.2013.10.002

Petukhov AI, Kornilov NN, Kulyaba TA. Injectable hyaluronic acid drugs for the treatment of knee osteoarthritis in the context of evidence-based medicine. Rheumatology Science and Practice [Internet]. Mediar Press; 2018 May 7;56(2):239–48. Available from: https://doi.org/10.14412/1995-4484-2018-239-248

Ottaviani RA, Wooley P, Song Z, Markel DC. Inflammatory and Immunological Responses to Hyaluronan Preparations. The Journal of Bone & Joint Surgery [Internet]. Ovid Technologies (Wolters Kluwer Health); 2007 Jan;89(1):148–57. Available from: https://doi.org/10.2106/jbjs.e.01135

Cake M, Read R, Edwards S, Smith MM, Burkhardt D, Little C, et al. Changes in gait after bilateral meniscectomy in sheep: effect of two hyaluronan preparations. Journal of Orthopaedic Science [Internet]. Elsevier BV; 2008 Nov;13(6):514–23. Available from: https://doi.org/10.1007/s00776-008-1279-6

Gomis A, Miralles A, Schmidt RF, Belmonte C. Intra-articular injections of hyaluronan solutions of different elastoviscosity reduce nociceptive nerve activity in a model of osteoarthritic knee joint of the guinea pig. Osteoarthritis and Cartilage [Internet]. Elsevier BV; 2009 Jun;17(6):798–804. Available from: https://doi.org/10.1016/j.joca.2008.11.013

Boettger M, Kümmel D, Harrison A, Schaible H-G. Evaluation of long-term antinociceptive properties of stabilized hyaluronic acid preparation (NASHA) in an animal model of repetitive joint pain. Arthritis Research & Therapy [Internet]. Springer Science and Business Media LLC; 2011;13(4):R110. Available from: https://doi.org/10.1186/ar3394

Chen CPC, Hsu CC, Pei Y-C, Chen RL, Zhou S, Shen H-C, et al. Changes of synovial fluid protein concentrations in supra-patellar bursitis patients after the injection of different molecular weights of hyaluronic acid. Experimental Gerontology [Internet]. Elsevier BV; 2014 Apr;52:30–5. Available from: https://doi.org/10.1016/j.exger.2014.01.016

Zhao H, Liu H, Liang X, Li Y, Wang J, Liu C. Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis. BioDrugs [Internet]. Springer Science and Business Media LLC; 2016 Jul 19;30(5):387–96. Available from: https://doi.org/10.1007/s40259-016-0186-1